TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.

Michael J Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.